Fig 7 - by Caspar A. S. Pouw (9579630)

“…This ratio, which we further scale to its value at week 18, displays a ≈100% growth between week 18 and 26, to confirm that the increment of passengers contributes only for 150% of the overall exposure time growth.…”

Data Sheet 1_Application of compost amended with biochar on the distribution of antibiotic resistance genes in a soil–cucumber system—from the perspective of high-dose fertilizatio... by Shuai Shi (333614)

“…Compared with those in the control treatment group, the absolute abundance of ermB, ermT, gyrA, qnrS, tetC, and intI1 decreased by 6–100% in the soil of the SBTC group. …”

Image 1_Bilateral dorsolateral prefrontal cortex high-frequency transcranial magnetic stimulation for consciousness recovery after traumatic brain injury: a case series.tif by Chun-Hung Chang (760118)

“…SPECT revealed reduced hypoperfusion in the bilateral frontal lobes, decreasing from 51% to 40% in Patient A and from 33% to 30% in Patient B. …”

Supplementary Material for: Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Te... by Akizawa T. (3588626)

“…<b><i>Methods:</i></b> Subjects receiving a stable dose of an erythropoiesis-stimulating agent were randomized to receive once-daily enarodustat at a dose of 2, 4, or 6 mg or placebo in a double-blind manner for 6 weeks (Period 1) followed by 24-week open treatment with enarodustat, adjusted in the range of 2–8 mg to maintain Hb within a target range (10.0–12.0 g/dL; Period 2). …”

ETCO₂ in an animal undergoing two-lung, left-lung, and right-lung ventilations via a standard endotracheal tube during cardiopulmonary resuscitation. by Dong Hyun Ryu (5095394)

“…Immediately after the endotracheal tube was advanced into the right main bronchus (point E), ETCO₂ decreased to 12.5 mmHg and remained between 10.0 and 11.0 mmHg after stabilization.…”

Supplementary file 1_Clinical application of combined anticoagulation therapy in anti-MDA5 antibody-positive associated interstitial lung disease-a retrospective study.docx by Ting Zhang (102583)

“…Objective<p>To explore the clinical efficacy of combined anticoagulation therapy in patients with anti-Melanoma Differentiation-Associated protein 5 (MDA5) antibody-positive associated interstitial lung disease.</p>Methods<p>A retrospective cohort study was conducted, which included 100 patients diagnosed with anti-MDA5 antibody-positive interstitial lung disease at our hospital between January 2022 and December 2024. …”

Data_Sheet_1_Wearable Technology May Assist in Retraining Foot Strike Patterns in Previously Injured Military Service Members: A Prospective Case Series.PDF by Donald L. Goss (9730145)

“…AVLR of the involved and uninvolved limb decreased 29% from initial [54.7 ± 13.2 bodyweights per sec (BW/s) and 55.1 ± 12.7 BW/s] to post-intervention (38.7 ± 10.1 BW/s and 38.9 ± 10.0 BW/s), respectively. …”

Data_Sheet_4_Wearable Technology May Assist in Retraining Foot Strike Patterns in Previously Injured Military Service Members: A Prospective Case Series.PDF by Donald L. Goss (9730145)

“…AVLR of the involved and uninvolved limb decreased 29% from initial [54.7 ± 13.2 bodyweights per sec (BW/s) and 55.1 ± 12.7 BW/s] to post-intervention (38.7 ± 10.1 BW/s and 38.9 ± 10.0 BW/s), respectively. …”

Data_Sheet_3_Wearable Technology May Assist in Retraining Foot Strike Patterns in Previously Injured Military Service Members: A Prospective Case Series.PDF by Donald L. Goss (9730145)

“…AVLR of the involved and uninvolved limb decreased 29% from initial [54.7 ± 13.2 bodyweights per sec (BW/s) and 55.1 ± 12.7 BW/s] to post-intervention (38.7 ± 10.1 BW/s and 38.9 ± 10.0 BW/s), respectively. …”

Data_Sheet_2_Wearable Technology May Assist in Retraining Foot Strike Patterns in Previously Injured Military Service Members: A Prospective Case Series.PDF by Donald L. Goss (9730145)

“…AVLR of the involved and uninvolved limb decreased 29% from initial [54.7 ± 13.2 bodyweights per sec (BW/s) and 55.1 ± 12.7 BW/s] to post-intervention (38.7 ± 10.1 BW/s and 38.9 ± 10.0 BW/s), respectively. …”

Domain organization of CRL4 subunits. by Zeba Rizvi (18071564)

Bar charts of hepatic mRNA expression levels of nuclear factor kappa B (NF-kB), interleukin (IL)-1β, IL-6, IL-10, interferon-γ (INF-γ), and transforming growth factor-β (TGF-β) in... by Taher Mohammadizad (19786989)

Effect of PfCullin-2 knock-down on parasite morphology. by Zeba Rizvi (18071564)

Bar charts of hepatic mRNA expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione peroxidase 1 (GPx1), superoxide dismutase 1 (SOD1), and catalase (CA... by Taher Mohammadizad (19786989)

Data_Sheet_1_Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions.docx by Mohamed A. Abdelnaim (16976001)

“…We report a comprehensive clinical, demographic, and treatment data for patients who were treated with DBS in our institution.…”

Scaling of Convex Hull Volume to Body Mass in Modern Primates, Non-Primate Mammals and Birds by Charlotte A. Brassey (499316)

“…We conclude that the convex hulling technique can be justifiably applied to the fossil record when a large proportion of the skeleton is preserved. …”

Loss of protein stability in the absence of myotubularin-MTMR12 interactions. by Vandana A. Gupta (142475)

“…<p>(A) Knockdown of <i>mtmr12</i> resulted in a strong decrease of myotubularin protein in <i>mtmr12</i> morphant zebrafish at 3 dpf by western blotting. …”

Zn²⁺ is required for the enhancement of NMDAR fEPSPS which requires NR2B-containing NMDARs and activation of Src family kinases (SFK). by John A. Sullivan (6018725)

“…<b>(B)</b> Summary of NMDAR fEPSP decrease versus baseline (100%) after 70 minutes drug application in slices treated with 1μM Ro25-6981 and those treated with Ro25-6981 plus 1μM ZnCl₂ (<i>P</i>>0.05; Student’s t-test). …”

Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer by Jeffrey A. Meyerhardt (158559)

“…Vandetanib and cetuximab treatment induced a sustained increase in plasma PlGF and a transient decrease in plasma sVEGFR1, but no changes in plasma VEGF and sVEGFR2.…”

Data Sheet 1_Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the ‘TreC Diabete’ platform (TELEMECHRON Study).docx by Alexia Giovanazzi (16816139)

“…System usability (from 42 responders in the intervention group) had a median score of 95 (range: 0–100), indicating a high level of satisfaction with the platform.…”